Chen, Xiangyang,Gao, Yingxiang,Liu, Chong,Ni, Haihong,Mulvihill, Mark
申请号:
AU2014324595
公开号:
AU2014324595B2
申请日:
2014.09.29
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).